These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 7505225)
1. Prostatic spiral versus prostatic urolume wallstent for urinary retention due to benign prostatic hyperplasia. A long-term comparative study. Guazzoni G; Montorsi F; Bergamaschi F; Consonni P; Bellinzoni P; Rigatti P Eur Urol; 1993; 24(3):332-6. PubMed ID: 7505225 [TBL] [Abstract][Full Text] [Related]
2. Long term experience with the prostatic spiral for urinary retention due to benign prostatic hyperplasia. Guazzoni G; Montorsi F; Colombo R; Di Girolamo V; Da Pozzo L; Rigatti P Scand J Urol Nephrol; 1991; 25(1):21-4. PubMed ID: 1710824 [TBL] [Abstract][Full Text] [Related]
3. The UroLume stent in the management of benign prostatic hyperplasia. Milroy E; Chapple CR J Urol; 1993 Nov; 150(5 Pt 2):1630-5. PubMed ID: 7692100 [TBL] [Abstract][Full Text] [Related]
4. The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia. Masood S; Djaladat H; Kouriefs C; Keen M; Palmer JH BJU Int; 2004 Dec; 94(9):1271-4. PubMed ID: 15610103 [TBL] [Abstract][Full Text] [Related]
5. [Long-term results and indications of intraurethral stents in elderly patients with prostatic hypertrophy complaining of urinary retention]. Takeda M; Takahashi H; Tsutsui T; Go H; Hatano A; Sato S; Sasagawa T; Sakata Y; Hiraiwa M; Ando T Hinyokika Kiyo; 1993 Nov; 39(11):1011-5. PubMed ID: 7505521 [TBL] [Abstract][Full Text] [Related]
6. A comparison of transrectal hyperthermia, transurethral thermotherapy, urolume wallstent, and prostatic spiral for benign prostatic hyperplasia patients at poor operative risk. Montorsi F; Guazzoni G; Bergamaschi F; Consonni P; Galli L; Rigatti P Prostate; 1994; 24(3):156-61. PubMed ID: 7509486 [TBL] [Abstract][Full Text] [Related]
7. The biodegradable self-reinforced poly-DL-lactic acid spiral stent compared with a suprapubic catheter in the treatment of post-operative urinary retention after visual laser ablation of the prostate. Pétas A; Talja M; Tammela TL; Taari K; Välimaa T; Törmälä P Br J Urol; 1997 Sep; 80(3):439-43. PubMed ID: 9313664 [TBL] [Abstract][Full Text] [Related]
8. The North American experience with the UroLume endoprosthesis as a treatment for benign prostatic hyperplasia: long-term results. The North American UroLume Study Group. Oesterling JE; Kaplan SA; Epstein HB; Defalco AJ; Reddy PK; Chancellor MB Urology; 1994 Sep; 44(3):353-62. PubMed ID: 7521091 [TBL] [Abstract][Full Text] [Related]
10. The titanium intraprostatic stent: the United States experience. Kaplan SA; Merrill DC; Mosely WG; Benson RC; Chiou RK; Fuselier HA; Parra RO J Urol; 1993 Nov; 150(5 Pt 2):1624-9. PubMed ID: 7692099 [TBL] [Abstract][Full Text] [Related]
11. Biodegradable braided poly(lactic-co-glycolic acid) urethral stent combined with dutasteride in the treatment of acute urinary retention due to benign prostatic enlargement: a pilot study. Kotsar A; Isotalo T; Juuti H; Mikkonen J; Leppiniemi J; Hänninen V; Kellomäki M; Talja M; Tammela TL BJU Int; 2009 Mar; 103(5):626-9. PubMed ID: 18990149 [TBL] [Abstract][Full Text] [Related]
12. The use of intraurethral prostatic spiral in high risk patients for surgery with benign prostatic hyperplasia. Ozgür GK; Sivrikaya A; Bilen R; Biberoğlu K; Gümele HR Int Urol Nephrol; 1993; 25(1):65-70. PubMed ID: 7685746 [TBL] [Abstract][Full Text] [Related]
13. The use of wallstents in patients with benign prostatic hyperplasia. Guazzoni G; Montorsi F; Rigatti P Arch Esp Urol; 1994 Nov; 47(9):927-31. PubMed ID: 7530950 [TBL] [Abstract][Full Text] [Related]
14. Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia. Carnevale FC; da Motta-Leal-Filho JM; Antunes AA; Baroni RH; Marcelino AS; Cerri LM; Yoshinaga EM; Cerri GG; Srougi M J Vasc Interv Radiol; 2013 Apr; 24(4):535-42. PubMed ID: 23434084 [TBL] [Abstract][Full Text] [Related]
15. A modified prostatic UroLume Wallstent for healthy patients with symptomatic benign prostatic hyperplasia: a European Multicenter Study. Guazzoni G; Montorsi F; Coulange C; Milroy E; Pansadoro V; Rubben H; Sarramon JP; Williams G Urology; 1994 Sep; 44(3):364-70. PubMed ID: 7521092 [TBL] [Abstract][Full Text] [Related]
16. Prostatic UroLume Wallstent for urinary retention due to advanced prostate cancer: a 1-year followup study. Guazzoni G; Montorsi F; Bergamaschi F; Consonni P; Rigatti P J Urol; 1994 Nov; 152(5 Pt 1):1530-2. PubMed ID: 7933192 [TBL] [Abstract][Full Text] [Related]
17. A good alternative to indwelling catheter owing to benign prostate hyperplasia in elderly: Memotherm prostatic stent. Bozkurt IH; Yalcinkaya F; Sertcelik MN; Zengin K; Ekici M; Yigitbasi O Urology; 2013 Nov; 82(5):1004-7. PubMed ID: 23992964 [TBL] [Abstract][Full Text] [Related]
18. [Role of urodynamics in implantation of prostatic stents]. Comeri G; Conti G; Cretarola E; Furgoni P; Gianneo E Arch Ital Urol Androl; 1995 Feb; 67(1):81-5. PubMed ID: 7538397 [TBL] [Abstract][Full Text] [Related]
19. [Urethral stent (Memotherm) for the treatment of benign prostatic hyperplasia]. Noda Y; Ujike T; Oka D; Takada S; Fujimoto N; Koide T Hinyokika Kiyo; 2003 Nov; 49(11):645-7. PubMed ID: 14719451 [TBL] [Abstract][Full Text] [Related]
20. Experience with a new intraurethral stent for high-risk patients with benign prostatic hypertrophy. Fuse H; Okumura A; Sakamoto M; Katayama T Int Urol Nephrol; 1993; 25(4):369-74. PubMed ID: 7506240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]